Patents by Inventor Yoichi Hiasa

Yoichi Hiasa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11491219
    Abstract: The present invention relates to a hepatitis B vaccine composition for spray-administration to nasal mucosa for preventing and treating hepatitis B, which comprises hepatitis B antigen and carboxy vinyl polymer.
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: November 8, 2022
    Assignees: TOKYO YAKUHIN KOGYO CO., LTD., TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE, JAPAN as represented by DIRECTOR GENERAL of National Institute of Infectious Diseases, KAGOSHIMA UNIVERSITY, NATIONAL UNIVERSITY CORPORATION EHIME UNIVERSITY
    Inventors: Taizou Kamishita, Takashi Miyazaki, Michinori Kohara, Takahiro Sanada, Yoichi Hiasa, Osamu Yoshida, Kyoko Kohara, Hideki Hasegawa
  • Publication number: 20210228712
    Abstract: A hepatitis B vaccine comprising a surface antigen particle that has only hepatitis B virus L protein or a variant thereof assembling on a lipid membrane to form the particle.
    Type: Application
    Filed: July 13, 2018
    Publication date: July 29, 2021
    Inventors: Michinori Kohara, Takahiro Sanada, Yoichi Hiasa, Kyoko Kohara, Yasumasa Goh, Yasunori Oda
  • Publication number: 20210187101
    Abstract: The present invention relates to a rhinovaccination system for preventing and treating hepatitis B, comprising a hepatitis B vaccine composition for administration to nasal mucosa in combination with a medical nozzle device.
    Type: Application
    Filed: June 4, 2019
    Publication date: June 24, 2021
    Inventors: Taizou KAMISHITA, Takashi MIYAZAKI, Yoichi HIASA, Fazle Akbar SHEIKH MOHAMMAD, Osamu YOSHIDA, Julio Cesar AGUILAR RUBIDO, Gerardo Enrique GUILLEN NIETO, Eduardo PENTON ARIAS
  • Publication number: 20200261568
    Abstract: The present invention relates to a hepatitis B vaccine composition for spray-administration to nasal mucosa for preventing and treating hepatitis B, which comprises hepatitis B antigen and carboxy vinyl polymer.
    Type: Application
    Filed: October 4, 2018
    Publication date: August 20, 2020
    Inventors: Taizou KAMISHITA, Takashi MIYAZAKI, Michinori KOHARA, Takahiro SANADA, Yoichi HIASA, Osamu YOSHIDA, Kyoko KOHARA, Hideki HASEGAWA
  • Patent number: 8277793
    Abstract: A prophylactic or therapeutic agent for a viral disease, characterized by combining 22?-methoxyolean-12-ene-3?,24(4?)-diol with an interferon as active ingredients is disclosed. The prophylactic or therapeutic agent of the present invention exhibits a high therapeutic effect by administering 22?-methoxyolean-12-ene-3?,24(4?)-diol and interferon as a combination thereof.
    Type: Grant
    Filed: July 6, 2007
    Date of Patent: October 2, 2012
    Assignee: Meiji Seika Pharma Co., Ltd.
    Inventors: Yoichi Hiasa, Hiroyuki Kuzuhara
  • Publication number: 20090324541
    Abstract: A prophylactic or therapeutic agent for a viral disease, characterized by combining 22?-methoxyolean-12-ene-3?,24(4?)-diol with an interferon as active ingredients is disclosed. The prophylactic or therapeutic agent of the present invention exhibits a high therapeutic effect by administering 22?-methoxyolean-12-ene-3?,24(4?)-diol and interferon as a combination thereof.
    Type: Application
    Filed: July 6, 2007
    Publication date: December 31, 2009
    Applicant: Meiji Seika Kaisha, Ltd
    Inventors: Yoichi Hiasa, Hiroyuki Kuzuhara